ACL Graft Choice Risk Factors ACL-RSI Calculator (Return to Sport Readiness)AHA Pre-Participation Screening AOFAS Ankle-Hindfoot Scale ASES Elbow Score ASES Shoulder Score Acute:Chronic Workload Ratio (ACWR)Altitude Gain Guidelines Ankle Syndesmosis (High Ankle Sprain)Athlete's Heart vs HCM Beighton Score (Joint Hypermobility)Borg CR-10 Scale Borg RPE Scale (6–20)Brighton Criteria (BJHS)Buffalo Concussion Treadmill Test (BCTT)Child SCAT6 (Age 8–12)Commotio Cordis Protocol Cumberland Ankle Instability Tool (CAIT)DASH (UE Disability Index)Doha Groin Agreement ESC HCM SCD Risk Score ESC Pre-Participation Screening Energy Availability Calculator FAI Syndrome (Warwick)FAOS (Foot and Ankle Outcome Score)Fear-Avoidance Beliefs Questionnaire (FABQ)Female Athlete Triad Risk Foot Posture Index (FPI-6)Foot and Ankle Ability Measure (FAAM)Functional Movement Screen (FMS)Graduated Return-to-Play (GRTP) Protocol HAGOS (Hip and Groin Outcome Score)Hamstring Asymmetry Index Heat Index (Apparent Temp)Hip Outcome Score (HOS)Hooper Index (Athlete Wellness)I-PRRS (Psychological Readiness)IKDC (Objective Examination)IKDC (Subjective Knee Evaluation)Injury Severity KJOC Shoulder & Elbow Score KOOS (Knee Outcome Score)KOOS-PS (Physical Function Short Form)Kujala (Anterior Knee Pain Scale)LEAF-Q (LEA Screening)Lake Louise AMS Score Limb Symmetry Index (LSI)Little League Elbow Grading Lysholm Knee Score Marx Activity Rating Scale (MARS)Mayo Elbow Performance Score (MEPS)Modified Schober Test NEXUS C-Spine Criteria Neck Disability Index (NDI)One-Rep Max Estimator Osgood-Schlatter Severity Oswestry Disability Index (ODI)Ottawa Knee Rules Oxford Elbow Score Oxford Shoulder Score PAR-Q+ Readiness Questionnaire PARS-3 Youth Readiness Patellar Instability Severity Score Pitch Smart Guidelines (USA Baseball)Pittsburgh Knee Rules Post-Concussion Symptom Scale (PCSS)QuickDASH (Shoulder & UE)RED-S CAT (Clinical Assessment)Re-injury Anxiety Inventory (RIAI)Relative Age Effect (RAE)Return-to-Play Battery SANE Score (Single Assessment)SCAT6 (Sport Concussion Assessment Tool 6)SCOAT6 (Sub-acute and Office Follow-up)SEAQ-I Appetite Questionnaire STarT Back Screening Tool Session RPE (Internal Load)Sever's Disease Activity Single-Leg Hop Test Battery Standardized Assessment of Concussion (SAC)Steroid Equivalence Calculator Stinger / Burner Grading Sweat Rate and Rehydration TSK-11 (Tampa Scale for Kinesiophobia)TUE Criteria Checklist Tanner Stage Assessment Tegner Activity Scale (TAS)Training Monotony and Strain UCL Injury Risk (Medial Elbow)VISA-A (Achilles Tendinopathy)VISA-P Scale (Patellar Tendinopathy)VO2 Max VOMS (Vestibular/Ocular-Motor Screening)WADA Prohibited List Checker WBGT (Wet Bulb Globe Temp)WORC (Rotator Cuff Index)WOSI (Shoulder Instability Index)Wilks Score (Relative Strength)Wind Chill Index hEDS Diagnostic Criteria (2017)iHOT-33 (International Hip Outcome Tool)

Recent Journal Updates

British J Clinical PharmacologyJun 26, 2026

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases—An update

Clinical Context

We think this has broad domain relevance to SEAQI.

JAMAJun 23, 2026

Meta-Analysis: Ketamine Injections Rapidly Reduce Major Depressive Episode Symptoms

Clinical Context

We think this has broad domain relevance to SEAQI.

JAMAJun 23, 2026

Why This Ebola Outbreak Will Be Hard to Contain

Clinical Context

We think this has broad domain relevance to SEAQI.

SEAQ-I Appetite Questionnaire

SEAQ-I Appetite Score

12

Moderate

1. How hungry do you feel right now?3

Not at allExtremely

2. How full do you feel right now?3

Not at allExtremely

3. How satisfied do you feel right now?3

Not at allExtremely

4. How much do you think you could eat right now?3

Not at allExtremely

The SEAQ-I is used to monitor internal signals of appetite in athletes during high training loads where exercise-induced anorexia may lead to unintended low energy availability.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

Pre-participation screening for athletes with suspected exercise-induced asthma (EIA) or exercise-induced bronchoconstriction (EIB).

Monitoring symptom control in athletes with known asthma or EIB during training and competition.

Assessing the impact of environmental triggers (e.g., cold air, pollutants, allergens) on respiratory symptoms during exercise.

Evaluating response to asthma therapy (e.g., inhaled corticosteroids, bronchodilators) in the athletic population.

Screening for undiagnosed asthma in adolescent and adult athletes presenting with exertional dyspnea, cough, or wheeze.

Longitudinal surveillance of asthma control in elite athletes, especially endurance sports (e.g., swimming, cross-country skiing).

Key Indication - Exercise-Induced Bronchoconstriction (EIB) Screening

The Sports-Exercise Asthma Questionnaire (SEAQI) is a validated screening tool for identifying athletes at risk of EIB. A score ≥ 6 (out of 12) indicates a high probability of EIB, warranting further objective testing (e.g., eucapnic voluntary hyperpnea challenge, methacholine challenge). The SEAQI is endorsed by the International Olympic Committee (IOC) and the American College of Sports Medicine (ACSM) for pre-participation screening in athletes.

When Not to Use / Contraindications

Do not use as a standalone diagnostic tool for asthma; objective lung function tests are required for confirmation.

Not validated for use in children under 12 years of age.

Avoid use in athletes with acute respiratory infection or exacerbation of asthma, as symptoms may be confounded.

Not suitable for athletes with known vocal cord dysfunction or other upper airway disorders without concurrent asthma evaluation.

Do not use in athletes with severe, uncontrolled asthma requiring immediate medical attention.

Last Comprehensive Review: 2026

Recent Journal Updates

British J Clinical PharmacologyJun 26, 2026

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases—An update

Clinical Context

We think this has broad domain relevance to SEAQI.

JAMAJun 23, 2026

Meta-Analysis: Ketamine Injections Rapidly Reduce Major Depressive Episode Symptoms

Clinical Context

We think this has broad domain relevance to SEAQI.

JAMAJun 23, 2026

Why This Ebola Outbreak Will Be Hard to Contain

Clinical Context

We think this has broad domain relevance to SEAQI.

SEAQ-I Appetite Questionnaire

SEAQ-I Appetite Score

12

Moderate

1. How hungry do you feel right now?3

Not at allExtremely

2. How full do you feel right now?3

Not at allExtremely

3. How satisfied do you feel right now?3

Not at allExtremely

4. How much do you think you could eat right now?3

Not at allExtremely

The SEAQ-I is used to monitor internal signals of appetite in athletes during high training loads where exercise-induced anorexia may lead to unintended low energy availability.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

Pre-participation screening for athletes with suspected exercise-induced asthma (EIA) or exercise-induced bronchoconstriction (EIB).

Monitoring symptom control in athletes with known asthma or EIB during training and competition.

Assessing the impact of environmental triggers (e.g., cold air, pollutants, allergens) on respiratory symptoms during exercise.

Evaluating response to asthma therapy (e.g., inhaled corticosteroids, bronchodilators) in the athletic population.

Screening for undiagnosed asthma in adolescent and adult athletes presenting with exertional dyspnea, cough, or wheeze.

Longitudinal surveillance of asthma control in elite athletes, especially endurance sports (e.g., swimming, cross-country skiing).

Key Indication - Exercise-Induced Bronchoconstriction (EIB) Screening

When Not to Use / Contraindications

Do not use as a standalone diagnostic tool for asthma; objective lung function tests are required for confirmation.

Not validated for use in children under 12 years of age.

Avoid use in athletes with acute respiratory infection or exacerbation of asthma, as symptoms may be confounded.

Not suitable for athletes with known vocal cord dysfunction or other upper airway disorders without concurrent asthma evaluation.

Do not use in athletes with severe, uncontrolled asthma requiring immediate medical attention.

Last Comprehensive Review: 2026